Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Sindhava, Vishal ^a   Woodman, Michael E ^a   Stevenson, Brian ^a   Bondada, Subbarao ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; TOLL LIKE RECEPTOR; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; AUTOREGULATION; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; B LYMPHOCYTE DIFFERENTIATION; BORRELIA HERMSII INFECTION; BORRELIA INFECTION; CELL ACTIVITY; CELL CYCLE G1 PHASE; CELL DIVISION; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PERITONEAL CAVITY; PROTEIN FUNCTION; WILD TYPE; ANIMAL; BORRELIA; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; DRUG EFFECT; DRUG POTENTIATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOGENICITY; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BORRELIA HERMSII; MURINAE; MUS;

ANIMALS; ANTIGENS, CD40; B-CELL ACTIVATING FACTOR; B-LYMPHOCYTE SUBSETS; BLOTTING, WESTERN; BORRELIA; CELL PROLIFERATION; CELLS, CULTURED; INTERLEUKIN-10; INTERLEUKIN-5; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; NF-KAPPA B; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 77955380255     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011445     Document Type: Article

References (57)

1. Goodnow CC (2007) Multistep pathogenesis of autoimmune disease. Cell 130: 25-35.
2. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
3. Wolf SD, Dittel BN, Hardardottir F, Janeway CA, Jr. (1996) Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184: 2271-2278.
4. Mizoguchi A, Bhan AK (2006) A case for regulatory B cells. J Immunol 176: 705-710.
5. Bouaziz JD, Yanaba K, Tedder TF (2008) Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 224: 201-214.
6. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity 28: 639-650.
7. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118: 3420-3430.
8. Goetz M, Atreya R, Ghalibafian M, Galle PR, Neurath MF (2007) Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 13: 1365-1368.
9. Montecino-Rodriguez E, Dorshkind K (2006) New perspectives in B-1 B cell development and function. Trends Immunol 27: 428-433.
10. Berland R, Wortis HH (2002) Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol 20: 253-300.
11. Haas KM, Poe JC, Steeber DA, Tedder TF (2005) B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 23: 7-18.
12. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, et al. (2003) The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 170: 3819-3827.
13. Rosado MM, Aranburu A, Capolunghi F, Giorda E, Cascioli S, et al. (2009) From the fetal liver to spleen and gut: the highway to natural antibody. Mucosal Immunol 2: 351-361.
14. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, et al. (2000) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192: 271-280.
15. Martin F, Oliver AM, Kearney JF (2001) Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 14: 617-629.
16. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T (1987) Rheumatoid factor secretion from human Leu-1+ B cells. Science 236: 81-83.
17. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S (1996) CD5- mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274: 1906-1909.
18. Morris DL, Rothstein TL (1993) Abnormal transcription factor induction through the surface immunoglobulin M receptor of B-1 lymphocytes. J Exp Med 177: 857-861.
19. Dasu T, Sindhava V, Clarke SH, Bondada S (2009) CD19 signaling is impaired in murine peritoneal and splenic B-1 B lymphocytes. Mol Immunol 46: 2655-2665.
20. Sen G, Wu HJ, Bikah G, Venkataraman C, Robertson DA, et al. (2002) Defective CD19-dependent signaling in B-1a and B-1b B lymphocyte subpopulations. Mol Immunol 39: 57-68.
21. Blenman KR, Duan B, Xu Z, Wan S, Atkinson MA, et al. (2006) IL-10 regulation of lupus in the NZM2410 murine model. Lab Invest 86: 1136-1148.
22. Shimomura Y, Mizoguchi E, Sugimoto K, Kibe R, Benno Y, et al. (2008) Regulatory role of B-1 B cells in chronic colitis. Int Immunol 20: 729-737.
23. Gururajan M, Jacob J, Pulendran B (2007) Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS ONE 2: e863.
24. Cole LE, Yang Y, Elkins KL, Fernandez ET, Qureshi N, et al. (2009) Antigenspecific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc Natl Acad Sci U S A 106: 4343-4348.
25. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438: 364-368.
26. Gavin AL, Hoebe K, Duong B, Ota T, Martin C, et al. (2006) Adjuvantenhanced antibody responses in the absence of toll-like receptor signaling. Science 314: 1936-1938.
27. Palm NW, Medzhitov R (2009) Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci U S A.
28. Alugupalli KR, Akira S, Lien E, Leong JM (2007) MyD88- and Bruton's tyrosine kinase-mediated signals are essential for T cell-independent pathogen-specific IgM responses. J Immunol 178: 3740-3749.
29. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
30. Fischer GM, Solt LA, Hastings WD, Yang K, Gerstein RM, et al. (2001) Splenic and peritoneal B-1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B-1 from splenic B-2 cells. Cell Immunol 213: 62-71.
31. Rothstein TL, Kolber DL (1988) Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J Immunol 140: 2880-2885. 32. Wong SC, Chew WK, Tan JE, Melendez AJ, Francis F, et al. (2002) Peritoneal CD5+ B-1 cells have signaling properties similar to tolerant B cells. J Biol Chem 277: 30707-30715.
32. Tangye SG, Weston KM, Raison RL (1998) Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells. Leuk Lymphoma 31: 121-130.
33. Marcelletti JF (1996) IL-10 inhibits lipopolysaccharide-induced murine B cell proliferation and cross-linking of surface antigen receptors or ligation of CD40 restores the response. J Immunol 157: 3323-3333.
34. Lin TZ, Fernandes H, Yauch R, Ponzio NM, Raveche E (1992) IL-10 production in a CD5+ B cell lymphoma arising in a CD4 monoclonal antibodytreated SJL mouse. Clin Immunol Immunopathol 65: 10-22.
35. Arnold LW, Pennell CA, McCray SK, Clarke SH (1994) Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 179: 1585-1595.
36. Neumann M, Wohlleben G, Chuvpilo S, Kistler B, Wirth T, et al. (1996) CD40, but not lipopolysaccharide and anti-IgM stimulation of primary B lymphocytes, leads to a persistent nuclear accumulation of RelB. J Immunol 157: 4862-4869.
37. Siebenlist U, Brown K, Claudio E (2005) Control of lymphocyte development by nuclear factor-kappaB. Nat Rev Immunol 5: 435-445.
38. Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ (2004) Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50. Clin Exp Immunol 135: 64-73.
39. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS, Jr. (1999) Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 274: 31868-31874.
40. Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, et al. (1998) Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes. Shock 10: 389-394.
41. Moon BG, Takaki S, Miyake K, Takatsu K (2004) The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production. J Immunol 172: 6020-6029.
42. Bolz DD, Sundsbak RS, Ma Y, Akira S, Weis JH, et al. (2006) Dual role of MyD88 in rapid clearance of relapsing fever Borrelia spp. Infect Immun 74: 6750-6760.
43. Woodman ME, Cooley AE, Avdiushko R, Bowman A, Botto M, et al. (2009) Roles for phagocytic cells and complement in controlling relapsing fever infection. J Leukoc Biol 86: 727-736.
44. Perrin GQ, Johnson HM, Subramaniam PS (1999) Mechanism of interleukin-10 inhibition of T-helper cell activation by superantigen at the level of the cell cycle. Blood 93: 208-216.
45. O'Farrell AM, Liu Y, Moore KW, Mui AL (1998) IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3- dependent and -independent pathways. Embo J 17: 1006-1018.
46. Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226: 205-218.
47. Chumley MJ, Dal Porto JM, Cambier JC (2002) The unique antigen receptor signaling phenotype of B-1 cells is influenced by locale but induced by antigen. J Immunol 169: 1735-1743.
48. Stoermann B, Kretschmer K, Duber S, Weiss S (2007) B-1a cells are imprinted by the microenvironment in spleen and peritoneum. Eur J Immunol 37: 1613-1620.
49. Amano M, Baumgarth N, Dick MD, Brossay L, Kronenberg M, et al. (1998) CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J Immunol 161: 1710-1717.
50. Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771-5777.
51. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM (2006) IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 177: 7076-7085.
52. Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, et al. (2007) BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med 204: 1959-1971.
53. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, et al. (2006) Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 312: 1669-1672.
54. Gururajan M, Simmons A, Dasu T, Spear BT, Calulot C, et al. (2008) Early growth response genes regulate B cell development, proliferation, and immune response. J Immunol 181: 4590-4602.
55. Lyons AB (2000) Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods 243: 147-154.
56. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, et al. (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33: 827-833.
57. Garcia-Monco JC, Miller NS, Backenson PB, Anda P, Benach JL (1997) A mouse model of Borrelia meningitis after intradermal injection. J Infect Dis 175: 1243-1245.